drugset / Press release
Phase 1b/2 Study of Margetuximab in Combination with Pembrolizumab Presented at 2018 ASCO Gastrointestinal Cancers Symposium
2018-01-18 · MacroGenics · original macrogenics.com ↗
Phase 1b/2 Study of Margetuximab in Combination with Pembrolizumab Presented at 2018 ASCO Gastrointestinal Cancers Symposium 19 KB
The release as fetched from its publisher. macrogenics.com ↗